1.
Drones over U.S. may pose security risks
INDIANAPOLIS, Aug. 20 (UPI) -- Indianapolis pharmaceutical giant Eli Lilly went on a shopping spree Wednesday, closing one major deal and reaching a purchase agreement for Posilac.
Lilly said Elanco, it's animal health division, reached an agreement to buy the dairy cow diet supplement Posilac from Monsanto for $300 million upfront and an undisclosed percentage of sales revenues, the company said.
Lilly will buy the sales force, the product and the Posilac plant in Augusta, Ga., the company said.
"Global dairy demand is increasing, outstripping supply and consumers are seeing rapidly rising prices," said Jeff Simmons, Elanco's president, said in a statement.
Lilly also announced it closed on a $64 million purchase of SGX Pharmaceuticals, Inc. of San Diego
Lilly said it would buy all the outstanding shares of the oncology drug development company for $3 per share. A majority of stockholders at a special meeting approved the transaction and "all other closing conditions have also been met," the company said.
|
|
|
| Additional Business News Stories | |
VIENNA, Feb. 10 (UPI) --
Oil prices were expected to trend higher as an improved U.S. economy and geopolitical risk in the Middle East weigh on markets, OPEC said.
|
ISLAMABAD, Pakistan, Feb. 10 (UPI) --
The last three of 18 new and upgraded F-16 fighter jets from the United States arrived in Pakistan, a report by the Indo-Asian News Service said.
|
For the first time since the condo crash of 2007, Florida median existing condo prices came roaring back 2011, rising by a hefty 5 percent on a quarter-to-quarter basis....
|
Doubts about the euro are not subsiding, new leadership or not, rescue plan or not.
|
| Stories | Photos | People | Comments |
View Caption
